{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Primary membranoproliferative glomerulonephritis",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Rituximab",
            "via": [],
            "to": "Primary membranoproliferative glomerulonephritis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "Eculizumab",
            "via": [],
            "to": "Primary membranoproliferative glomerulonephritis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Mycophenolate mofetil",
            "via": [],
            "to": "Primary membranoproliferative glomerulonephritis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "Cyclophosphamide",
            "via": [],
            "to": "Primary membranoproliferative glomerulonephritis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasma_exchange",
          "type": "Drug",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexamethasone",
          "type": "Drug",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_primary_membranoproliferative_glomerulonephritis",
          "type": "Disease",
          "label": "Primary membranoproliferative glomerulonephritis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Sirolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Bortezomib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Belimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_rituximab",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已有研究表明 Rituximab 能改善某些类型的肾小管病"
        },
        {
          "source": "drug_eculizumab",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Eculizumab 对单抗相关肾病有效"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已用于多种免疫介导条件下的肾脏病"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "常用于系统性疾病导致的肾小管病"
        },
        {
          "source": "drug_tacrolimus",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Tacrolimus 在肾移植患者中有效"
        },
        {
          "source": "drug_prednisone",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "经典的免疫抑制治疗"
        },
        {
          "source": "drug_azathioprine",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "有助于抑制自身免疫反应"
        },
        {
          "source": "drug_sirolimus",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能对特定肾病类型有效"
        },
        {
          "source": "drug_plasma_exchange",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "在重症患者中使用此疗法"
        },
        {
          "source": "drug_bortezomib",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "对特定类型的病理有效"
        },
        {
          "source": "drug_belimumab",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "影响B淋巴细胞，可能改善病情"
        },
        {
          "source": "drug_dexamethasone",
          "target": "disease_primary_membranoproliferative_glomerulonephritis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "类固醇在免疫介导病中有效"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_rituximab",
              "target": "disease_primary_membranoproliferative_glomerulonephritis",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "Rituximab 可通过靶向 B 细胞减轻免疫介导的肾小管损伤"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已增加 Rituximab 对于 Primary membranoproliferative glomerulonephritis 的支持性链"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_eculizumab",
              "target": "disease_primary_membranoproliferative_glomerulonephritis",
              "relation": "acts_on",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "Eculizumab 可通过抑制补体途径减轻肾小管损害"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已增加 Eculizumab 对于 Primary membranoproliferative glomerulonephritis 的支持性链"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_mycophenolate_mofetil",
              "target": "disease_primary_membranoproliferative_glomerulonephritis",
              "relation": "acts_on",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "Mycophenolate mofetil 通过抑制淋巴细胞增殖可改善肾小管病"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已增加 Mycophenolate mofetil 对于 Primary membranoproliferative glomerulonephritis 的支持性链"
      },
      {
        "action_ref": 3,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_cyclophosphamide",
              "target": "disease_primary_membranoproliferative_glomerulonephritis",
              "relation": "acts_on",
              "weight": 0.6,
              "agent": "Proponent",
              "rationale": "Cyclophosphamide 能通过免疫抑制改善肾小管病"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已增加 Cyclophosphamide 对于 Primary membranoproliferative glomerulonephritis 的支持性链"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": [
      "尚需进一步验证药物的临床应用效果与机制"
    ]
  }
}